JPH0358352B2 - - Google Patents

Info

Publication number
JPH0358352B2
JPH0358352B2 JP10469983A JP10469983A JPH0358352B2 JP H0358352 B2 JPH0358352 B2 JP H0358352B2 JP 10469983 A JP10469983 A JP 10469983A JP 10469983 A JP10469983 A JP 10469983A JP H0358352 B2 JPH0358352 B2 JP H0358352B2
Authority
JP
Japan
Prior art keywords
group
general formula
rifamycin
phenothiazine
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP10469983A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59231092A (ja
Inventor
Masahiro Taguchi
Mikya Kitamura
Koji Inai
Norio Aikawa
Goro Tsukamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP10469983A priority Critical patent/JPS59231092A/ja
Publication of JPS59231092A publication Critical patent/JPS59231092A/ja
Publication of JPH0358352B2 publication Critical patent/JPH0358352B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP10469983A 1983-06-11 1983-06-11 フエノチアジン型リフアマイシンおよびその医薬用途 Granted JPS59231092A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10469983A JPS59231092A (ja) 1983-06-11 1983-06-11 フエノチアジン型リフアマイシンおよびその医薬用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10469983A JPS59231092A (ja) 1983-06-11 1983-06-11 フエノチアジン型リフアマイシンおよびその医薬用途

Publications (2)

Publication Number Publication Date
JPS59231092A JPS59231092A (ja) 1984-12-25
JPH0358352B2 true JPH0358352B2 (enrdf_load_stackoverflow) 1991-09-05

Family

ID=14387724

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10469983A Granted JPS59231092A (ja) 1983-06-11 1983-06-11 フエノチアジン型リフアマイシンおよびその医薬用途

Country Status (1)

Country Link
JP (1) JPS59231092A (enrdf_load_stackoverflow)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1304363C (en) * 1988-11-01 1992-06-30 Takehiko Yamane 3'-hydroxybenzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same
WO1997009047A1 (fr) * 1995-09-01 1997-03-13 Kaneka Corporation Medicament contre des maladies causees par une infection par helicobacter
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
ES2237809T3 (es) * 1997-02-28 2005-08-01 Kaneka Corporation Medicina curativa para la enfermedad causada por infeccion de helicobacter.
CA2536378A1 (en) 2003-08-22 2005-03-10 Activbiotics, Inc. Rifamycin analogs and uses thereof
WO2005058231A2 (en) 2003-12-10 2005-06-30 Activbiotics, Inc. Rifamycin analogs and uses thereof
KR20070006698A (ko) 2003-12-23 2007-01-11 액티브 바이오틱스 인코포레이티드 리파마이신 유사체 및 그의 용도
JP7591503B2 (ja) * 2018-12-21 2024-11-28 リジェネロン ファーマシューティカルズ，インク． リファマイシンアナログおよびその抗体薬物コンジュゲート

Also Published As

Publication number Publication date
JPS59231092A (ja) 1984-12-25

Similar Documents

Publication Publication Date Title
DE68919650T2 (de) 3'-Hydroxysubstituiertes Benzoxazinorifamycinderivat, Verfahren zu seiner Herstellung und dieses enthaltendes antibakterielles Mittel.
EP1438298B1 (en) Piperazine derivatives with ccr1 receptor antagonist activity
US5350582A (en) Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof
JPH02104526A (ja) 高血圧症治療用組成物
CS244148B2 (en) Method of aminomethylpyrrolidine production
JPH0358352B2 (enrdf_load_stackoverflow)
JPS63501712A (ja) 置換４−ベンジルピペラジニル化合物
DE69720317T2 (de) Benzoxazole Derivate als Serotonin 5-HT3 Rezeptor partiell Aktivator
US4965261A (en) Substituted benzoxazinorifamycin derivative and antibacterial agent containing the same
US3974274A (en) Process for preparing a cyclodextrin derivative
WO2019003076A1 (en) PYRIDO-IMIDAZO-RIFAMYCIN DERIVATIVES AS ANTIBACTERIAL AGENT
DE69215482T2 (de) 2,2'-Alkylendiindolderivate, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung als Ulcustherapeutikum
EP0065295A1 (de) Substituierte Tryptaminderivate von Thienyloxypropanolaminen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen sowie ihre Verwendung
ATE23160T1 (de) Neue pyridobenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
EP0787494B1 (en) Use of rifamycin derivatives for the manufacture of a medicament for the treatment of diseases caused by infections of helicobacter pylori
CA1077961A (en) Aralkyl amides having antidepressive activity
SU1187723A3 (ru) Способ получени гидрохлорида 2-оксиметил- 6 -метил- 4- @ - толилтиено/2,3 - @ / пиперидина
US3987199A (en) Substituted benzenesulfonamides as anthelmintics
DE69029814T2 (de) Inhibitoren der dihydrofolatreduktase von pneumocystis carinii
DE2409262A1 (de) Imidazo eckige klammer auf 1,2-a eckige klammer zu azacycloalkane
JPS6122090A (ja) アミノ置換フエノチアジン型リフアマイシンおよびその医薬用途
EP0014569B1 (en) (-)-alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-2-pyridineacetamide and pharmacologically acceptable salts thereof, process for the production thereof and compositions containing the same
US3721742A (en) Anthelmintic method and formulations employing phenylhydrazone derivatives
KR20150042275A (ko) 3-포르밀리파마이신 sv 및 3-포르밀리파마이신 s의 3-(4-신나밀-l-피페라지닐) 아미노 유도체를 함유하는 제약 제제 및 그의 제조 방법
EP0075165A1 (de) 9,10-Substituierte 2-Mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2H-pyrimido(6,1-a)isochinolin-4-one, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel